COMPANIES
Resources
Principal content
Turning the world of drugs upside down
When Abbas Hussain was recruited by GlaxoSmith-Kline’s chief executive Andrew Witty last year to head emerging markets, the idea was to shift the pharmaceutical company away from ‘white pills in western markets’
Glaxo hopes high for Cambridge science centre
GlaxoSmithKline is to spearhead the development of a £170m biotech science park in an effort to create a life sciences cluster in the east of England that can rival the leading US centres of Boston and North Carolina
Tests boosts Immunodiagnostic Systems
The surging popularity of vitamin D tests has lifted profits at the medical testing company as it promotes a new system that will greatly increase medical diagnosis
Forgetful patients lift support consultancies
A growing number of companies are being sought out by pharmaceutical groups as they explore strategic ways to improve patient “adherence”
Hutchison plans China beauty push
A.S. Watson Group opens its 500th mainland store, as the retail unit of Hutchison Whampoa plans to double its presence amid signs of its increasing popularity in the country
NHS patients boost General Healthcare
Increased business from NHS-funded patients more than compensates for a decline in the numbers of private-pay customers at the private hospitals group
NHS contractors in blackmail probe
Three managers have been arrested over an alleged immigration scam after a raid on the offices of ISS Mediclean at Kingston Hospital in Surrey, where the organisation is responsible for cleaning, catering, car parking and security
Property concerns prompt NHS probe
An inquiry is being opened into how far the health service should retain control of its property when it puts services out to tender or allows mergers and takeovers
Care UK profits up 25%
The pressures on local authority budgets will result in more business for private sector care services, Care UK says, as the health and care group reports a 25 per cent rise in full-year profits
Isis drug stake set for solid returns
ScriptSwitch, the drug comparison software company, has been acquired by US-based UnitedHealth, generating a four-fold return for the Coventry-based group’s private equity backers






